Edition:
India

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

45.05USD
15 Jun 2018
Change (% chg)

$-0.60 (-1.31%)
Prev Close
$45.65
Open
$45.50
Day's High
$46.15
Day's Low
$44.55
Volume
368,357
Avg. Vol
234,387
52-wk High
$54.45
52-wk Low
$11.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -1.047
FY 2017 Dec '17 0.00 -1.152
Sep '17 0.00 -1.020
Jun '17 0.00 -0.938
Mar '17 0.00 -0.883
FY 2016 Dec '16 0.00 -0.631
Sep '16 0.00 -0.881
Jun '16 0.00 -0.659
Mar '16 0.00 -0.580
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 6.00
Year Ending Dec-19 6 0.83 2.98 0.00 80.73
Earnings (per share)
Quarter Ending Jun-18 7 -0.98 -0.84 -1.09 -0.96
Quarter Ending Sep-18 7 -1.00 -0.84 -1.10 -0.91
Year Ending Dec-18 7 -4.01 -3.58 -4.31 -3.82
Year Ending Dec-19 7 -4.23 -3.94 -4.69 -2.47
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Atara Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.46 5.69 99 --
13 Week 8.72 3.43 99 --
26 Week -5.26 -12.46 99 --
52 Week -8.06 -22.07 99 --
YTD 14.08 0.19 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 172
Total Shares Held: 48,250,524
3 Mo. Net Change: 13,847,701
# New Positions: 52
# Closed Positions: 12
# Increased Positions: 123
# Reduced Positions: 32
# Net Buyers: 91
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.